EUVIMEDEUVIMED entdecken
Crossref

Biochemical recurrence, salvage treatment, and long-term oncological outcomes after radical prostatectomy for International Society of Urological Pathology grade group 2 prostate cancer

Lucas Diéguez-Álvarez, Sara Gil-Carballal, Ana Castelló-Porcar, José María Martínez-Jabaloyas

Indian Journal of Urology · 28.10.2026

DOI: 10.4103/iju.iju_340_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Urology, online erschienen am 28.10.2026. Verfasst von Lucas Diéguez-Álvarez und 3 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

International Society of Urological Pathology (ISUP) grade group (GG) 2 is the most common grade at radical prostatectomy (RP), yet its long-term natural history is poorly defined. We evaluated the predictors of biochemical recurrence (BCR) and the relationship between BCR, salvage treatment, and oncological outcomes.

Methods

We analyzed 224 consecutive patients with confirmed GG2 prostate cancer after RP between 1999 and 2015. BCR was defined as two consecutive prostate-specific antigen ≥0.2 ng/mL. Kaplan–Meier and competing-risk analyses were performed, and predictors of BCR were assessed using multivariable Cox regression analysis.

Results

Median follow-up was 209 months. BCR occurred in 91 patients (40.6%) after a median of 47 months. Ten-year BCR-free survival was 62.0%, 72.5% with negative surgical margins, and 51.9% with positive margins ( P < 0.001). Positive surgical margin (PSM) was the only independent predictor of BCR (hazard ratio: 2.29, 95% confidence interval 1.40–3.75; P = 0.001). No patient received adjuvant radiotherapy. Among 91 patients with BCR, 35 (38.5%) received no salvage treatment; after 107 months’ median follow-up from recurrence, none developed metastasis or died from prostate cancer. Metastasis developed in 8 patients (3.6%) and prostate cancer-specific death occurred in 2 (0.9%). Twenty-year metastasis-free and cancer-specific survival were 95.4% and 97.9%, respectively.

Conclusions

In our cohort, PSM was the main predictor of BCR, whereas metastatic progression and prostate cancer-specific death after BCR were uncommon. Favorable outcomes were observed among recurrent patients managed without salvage treatment, although nonrandom treatment allocation and the limited number of progression events preclude causal inference.

Zitieren

APA

Diéguez-Álvarez, L., Gil-Carballal, S., Castelló-Porcar, A., & Martínez-Jabaloyas, J. M. (2026). Biochemical recurrence, salvage treatment, and long-term oncological outcomes after radical prostatectomy for International Society of Urological Pathology grade group 2 prostate cancer. Indian Journal of Urology. https://doi.org/10.4103/iju.iju_340_26

Vancouver

Diéguez-Álvarez L, Gil-Carballal S, Castelló-Porcar A, Martínez-Jabaloyas JM. Biochemical recurrence, salvage treatment, and long-term oncological outcomes after radical prostatectomy for International Society of Urological Pathology grade group 2 prostate cancer. Indian Journal of Urology. 2026. doi:10.4103/iju.iju_340_26

BibTeX
@article{Diguezlvarez2026,
  author = {Diéguez-Álvarez, Lucas and Gil-Carballal, Sara and Castelló-Porcar, Ana and Martínez-Jabaloyas, José María},
  title = {Biochemical recurrence, salvage treatment, and long-term oncological outcomes after radical prostatectomy for International Society of Urological Pathology grade group 2 prostate cancer},
  journal = {Indian Journal of Urology},
  year = {2026},
  doi = {10.4103/iju.iju_340_26}
}
Kostenlos starten →